Is Cyclophosphamide Self-defeating As an Antitumor Agents?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The study shows inhibition of the antitumor effect of cyclophosphamide (CPA) on mammary carcinomas growing in mice prior-immunized by intragastric inoculations of the tumor. Immunization with tumor cells through this route produces under certain conditions factors able to modulate the antigenic determinants on tumor cells. The possibility that the antigenicity of tumor cells might be an important factor in obtaining successful therapy with CPA is proposed.
References
1.
Laursen M
. Serological response to intracaecal injections of antigenic mouse tumour cells. Br J Cancer. 1978; 38(6):692-8.
PMC: 2009818.
DOI: 10.1038/bjc.1978.274.
View
2.
Griswold D, Heppner G, Calabresi P
. Selective suppression of humoral and cellular immunity with cytosine arabinoside. Cancer Res. 1972; 32(2):298-301.
View
3.
Bremberg S
. The influence of host factors on cyclophosphamide treatment of Moloney virus-induced lymphomas. Eur J Cancer (1965). 1970; 6(4):277-86.
DOI: 10.1016/0014-2964(70)90091-5.
View
4.
Laursen M, Laursen K
. Enhancement of tumour growth in two syngeneic C3H murine systems by immunization via the intracaecal route. Br J Cancer. 1978; 37(6):1039-45.
PMC: 2009641.
DOI: 10.1038/bjc.1978.151.
View
5.
Heppner G, Calabresi P
. Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors. J Natl Cancer Inst. 1972; 48(4):1161-7.
View